UPDATE 1-Vertex Pharma receives subpoena from Department of Justice

Oct 30 (Reuters) - Vertex Pharmaceuticals Inc said it received a subpoena from the U.S. Department of Justice in the third quarter related to its marketed medicines, seeking documents related primarily to its "good laboratory practices" in a bioanalytical lab.